Unknown

Dataset Information

0

CYP21A2 mutations in pediatric patients with congenital adrenal hyperplasia in Costa Rica.


ABSTRACT: Steroid 21-hydroxylase deficiency accounts for 95% of congenital adrenal hyperplasia (CAH) cases. Newborn screening has allowed for early detection of the disease, and currently, molecular analysis can identify the genotypes of these patients. Phenotype-genotype correlation has been well described in previous studies. In Costa Rica, there is no data about the genetic background of these patients, nor their phenotypic correlation.

Design

Observational, retrospective, descriptive study based on the review of patient records who had a diagnosis of CAH and were performed molecular analysis using gene sequencing or MLPA during the period from 2006 to 2018 (N = 58).

Objective

To describe the clinical and genetic characteristics of CAH patients due to 21-hydroxylase deficiency at the National Children's Hospital "Dr. Carlos Sáenz Herrera", Caja Costarricense de Seguro Social (CCSS) in Costa Rica.

Results

53% (31/58) of the patients were male and 80% (37/46) were born full term; 72% (42/58) had salt wasting phenotype, 9% (5/58) simple virilizing phenotype and 19% (11/58) non-classic phenotype. The most frequent variants were c.292+5G>A in 26% (15/58) of patients and Del/Del in 21% (12/58) of them.

Conclusions

The most frequent mutation in our study population was the c.292+5G>A, which was found in 15/58 patients. This rare variant has only been reported in three other studies so far but as an infrequent mutation in CAH patients. The genetic characteristics of Costa Rican patients differ from what has been documented worldwide and could respond to a founder effect.

SUBMITTER: Umana-Calderon A 

PROVIDER: S-EPMC7875833 | biostudies-literature | 2021 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

<i>CYP21A2</i> mutations in pediatric patients with congenital adrenal hyperplasia in Costa Rica.

Umaña-Calderón Andrés A   Acuña-Navas María José MJ   Alvarado Danny D   Jiménez Mildred M   Cavallo-Aita Fred F  

Molecular genetics and metabolism reports 20210209


Steroid 21-hydroxylase deficiency accounts for 95% of congenital adrenal hyperplasia (CAH) cases. Newborn screening has allowed for early detection of the disease, and currently, molecular analysis can identify the genotypes of these patients. Phenotype-genotype correlation has been well described in previous studies. In Costa Rica, there is no data about the genetic background of these patients, nor their phenotypic correlation.<h4>Design</h4>Observational, retrospective, descriptive study base  ...[more]

Similar Datasets

| S-EPMC3574933 | biostudies-literature
| S-EPMC3987286 | biostudies-literature
| S-EPMC6503067 | biostudies-literature
| S-EPMC4566346 | biostudies-literature
| S-EPMC6702941 | biostudies-literature
| S-EPMC5121304 | biostudies-literature
| S-EPMC8001222 | biostudies-literature
| S-EPMC6177667 | biostudies-literature
| S-EPMC3493742 | biostudies-literature
| S-EPMC3050769 | biostudies-literature